The expression of p38/MAPK and IL-6 in the pulmonary vessels of IPAH patients increased, as demonstrated the fact that p38/MAPK antagonists was able to reduce IL-6 in PH rat models (114). Here, IL6 is linked to idiopathic pulmonary arterial hypertension.